Latest Profitability News

Saferoads Holdings reports a $192k operating cash use impacted by strategic prepayments, completes its Road Safety Rentals asset sale, and maintains strong cash reserves after paying a substantial dividend.

Sandon Capital Investments announces a fully franked 1.4 cent dividend for the September quarter, reflecting robust FY2025 portfolio returns and a healthy dividend yield.

Bowen Coking Coal reported record operating cashflows of $19.1 million in the June 2025 quarter, achieving all FY2025 guidance despite heavy rains and logistical hurdles. The company has launched a low-cost mining strategy while negotiating liquidity solutions amid depressed coal prices.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

Compumedics has secured two significant four-year distribution agreements in China worth A$24.4 million, reinforcing its strategic foothold in Asia with committed annual growth of at least 10%.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.

Pureprofile has reported record FY25 results, with revenue climbing 19% and EBITDA up 18%, driven by strong international growth and innovative AI platform launches.

Prospect Resources has kicked off an extensive Phase 2 drilling campaign at its Mumbezhi Copper Project in Zambia, confirming promising copper grades and advancing metallurgical testing. A strategic $18.5 million investment from First Quantum Minerals strengthens its financial and technical position.

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.

Australian Foundation Investment Company Limited (AFIC) reported a $285 million net profit for FY2025, declaring a fully franked 14.5c final dividend plus a 5c special dividend tied to capital gains from portfolio adjustments.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.